GLN-GABAPENTIN
Identification of Gln-Gabapentin
| No description |
Google image searchProduct monograph
Active ingredient
gabapentin, 600 MG
DIN: 02410990
Dosage form(s): TABLET (IMMEDIATE RELEASE)
Route(s) of administration: ORAL
Schedule: Prescription
Company: GLENMARK PHARMACEUTICALS CANADA INC.
Date: 27-SEP-2019
ATC:
- N02 — ANALGESICS (ATC, ATC/DDD, )
- N02B — OTHER ANALGESICS AND ANTIPYRETICS (ATC, ATC/DDD)
- N02BF — Gabapentinoids (ATC, ATC/DDD)
- N02BF01 — GABAPENTIN (ATC/DDD)
Reference brand drug: Neurontin
Pharmaceutical standard: USP
